Cargando…

Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly

Pulmonary fibrosis (PF) is a progressive and irreversible condition with various causes, and no effective treatment has been found to rescue fibrotic lungs. Successful recovery from PF requires inhibiting inflammation, promoting collagen degradation and stimulating alveolar regeneration. Human umbil...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Kuo-An, Wang, Shih-Yao, Yeh, Chang-Ching, Fu, Tz-Win, Fu, Yu-Yi, Ko, Tsui-Ling, Chiu, Mei-Miao, Chen, Tien-Hua, Tsai, Pei-Jiun, Fu, Yu-Show
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771241/
https://www.ncbi.nlm.nih.gov/pubmed/31588241
http://dx.doi.org/10.7150/thno.33741
_version_ 1783455656939880448
author Chu, Kuo-An
Wang, Shih-Yao
Yeh, Chang-Ching
Fu, Tz-Win
Fu, Yu-Yi
Ko, Tsui-Ling
Chiu, Mei-Miao
Chen, Tien-Hua
Tsai, Pei-Jiun
Fu, Yu-Show
author_facet Chu, Kuo-An
Wang, Shih-Yao
Yeh, Chang-Ching
Fu, Tz-Win
Fu, Yu-Yi
Ko, Tsui-Ling
Chiu, Mei-Miao
Chen, Tien-Hua
Tsai, Pei-Jiun
Fu, Yu-Show
author_sort Chu, Kuo-An
collection PubMed
description Pulmonary fibrosis (PF) is a progressive and irreversible condition with various causes, and no effective treatment has been found to rescue fibrotic lungs. Successful recovery from PF requires inhibiting inflammation, promoting collagen degradation and stimulating alveolar regeneration. Human umbilical mesenchymal stem cells (HUMSCs) not only regulate immune responses but also synthesize and release hyaluronan to improve lung regeneration. This study investigated the feasibility of HUMSC engraftment into rats with bleomycin (BLM)-induced PF to explore HUMSC therapeutic effects/outcomes. Methods: A unique BLM-induced left-lung-dominated PF animal model was established. Rats were transplanted with low-dose (5×10(6)) or high-dose (2.5×10(7)) HUMSCs on Day 21 after BLM injection. Combinations in co-culture of pulmonary macrophages, fibroblasts, HUMSCs treated with BLM and the same conditions on alveolar epithelia versus HUMSCs were evaluated. Results: Rats with high-dose HUMSC engraftment displayed significant recovery, including improved blood oxygen saturation levels and respiratory rates. High-dose HUMSC transplantation reversed alveolar injury, reduced cell infiltration and ameliorated collagen deposition. One month posttransplantation, HUMSCs in the rats' lungs remained viable and secreted cytokines without differentiating into alveolar or vascular epithelial cells. Moreover, HUMSCs decreased epithelial-mesenchymal transition in pulmonary inflammation, enhanced macrophage matrix-metallopeptidase-9 (MMP-9) expression for collagen degradation, and promoted toll-like receptor-4 (TLR-4) expression in the lung for alveolar regeneration. In coculture studies, HUMSCs elevated the MMP-9 level in pulmonary macrophages, released hyaluronan into the medium and stimulated the TLR-4 quantity in the alveolar epithelium. Principal Conclusions: Transplanted HUMSCs exhibit long-term viability in rat lungs and can effectively reverse rat PF.
format Online
Article
Text
id pubmed-6771241
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-67712412019-10-06 Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly Chu, Kuo-An Wang, Shih-Yao Yeh, Chang-Ching Fu, Tz-Win Fu, Yu-Yi Ko, Tsui-Ling Chiu, Mei-Miao Chen, Tien-Hua Tsai, Pei-Jiun Fu, Yu-Show Theranostics Research Paper Pulmonary fibrosis (PF) is a progressive and irreversible condition with various causes, and no effective treatment has been found to rescue fibrotic lungs. Successful recovery from PF requires inhibiting inflammation, promoting collagen degradation and stimulating alveolar regeneration. Human umbilical mesenchymal stem cells (HUMSCs) not only regulate immune responses but also synthesize and release hyaluronan to improve lung regeneration. This study investigated the feasibility of HUMSC engraftment into rats with bleomycin (BLM)-induced PF to explore HUMSC therapeutic effects/outcomes. Methods: A unique BLM-induced left-lung-dominated PF animal model was established. Rats were transplanted with low-dose (5×10(6)) or high-dose (2.5×10(7)) HUMSCs on Day 21 after BLM injection. Combinations in co-culture of pulmonary macrophages, fibroblasts, HUMSCs treated with BLM and the same conditions on alveolar epithelia versus HUMSCs were evaluated. Results: Rats with high-dose HUMSC engraftment displayed significant recovery, including improved blood oxygen saturation levels and respiratory rates. High-dose HUMSC transplantation reversed alveolar injury, reduced cell infiltration and ameliorated collagen deposition. One month posttransplantation, HUMSCs in the rats' lungs remained viable and secreted cytokines without differentiating into alveolar or vascular epithelial cells. Moreover, HUMSCs decreased epithelial-mesenchymal transition in pulmonary inflammation, enhanced macrophage matrix-metallopeptidase-9 (MMP-9) expression for collagen degradation, and promoted toll-like receptor-4 (TLR-4) expression in the lung for alveolar regeneration. In coculture studies, HUMSCs elevated the MMP-9 level in pulmonary macrophages, released hyaluronan into the medium and stimulated the TLR-4 quantity in the alveolar epithelium. Principal Conclusions: Transplanted HUMSCs exhibit long-term viability in rat lungs and can effectively reverse rat PF. Ivyspring International Publisher 2019-09-17 /pmc/articles/PMC6771241/ /pubmed/31588241 http://dx.doi.org/10.7150/thno.33741 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Chu, Kuo-An
Wang, Shih-Yao
Yeh, Chang-Ching
Fu, Tz-Win
Fu, Yu-Yi
Ko, Tsui-Ling
Chiu, Mei-Miao
Chen, Tien-Hua
Tsai, Pei-Jiun
Fu, Yu-Show
Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
title Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
title_full Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
title_fullStr Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
title_full_unstemmed Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
title_short Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
title_sort reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from wharton's jelly
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771241/
https://www.ncbi.nlm.nih.gov/pubmed/31588241
http://dx.doi.org/10.7150/thno.33741
work_keys_str_mv AT chukuoan reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT wangshihyao reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT yehchangching reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT futzwin reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT fuyuyi reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT kotsuiling reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT chiumeimiao reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT chentienhua reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT tsaipeijiun reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly
AT fuyushow reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly